Cleared Traditional

K253303 - Dendrite Imaging System (FDA 510(k) Clearance)

Nov 2025
Decision
60d
Days
Class 2
Risk

K253303 is an FDA 510(k) clearance for the Dendrite Imaging System. This device is classified as a Parathyroid Autofluorescence Imaging Device (Class II - Special Controls, product code QDG).

Submitted by Dendrite Imaging, Inc. (Berkeley, US). The FDA issued a Cleared decision on November 28, 2025, 60 days after receiving the submission on September 29, 2025.

This device falls under the General & Plastic Surgery FDA review panel. Regulated under 21 CFR 878.4550. An Autofluorescence Detection Device For General Surgery And Dermatological Use Is An Adjunct Tool That Uses Autofluorescence To Detect Tissues Or Structures. This Device Is Not Intended To Provide A Diagnosis..

Submission Details

510(k) Number K253303 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 29, 2025
Decision Date November 28, 2025
Days to Decision 60 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF

Device Classification

Product Code QDG - Parathyroid Autofluorescence Imaging Device
Device Class Class II - Special Controls
CFR Regulation 21 CFR 878.4550
Definition An Autofluorescence Detection Device For General Surgery And Dermatological Use Is An Adjunct Tool That Uses Autofluorescence To Detect Tissues Or Structures. This Device Is Not Intended To Provide A Diagnosis.